Correlation Between Virpax Pharmaceuticals and Bionomics
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Bionomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Bionomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Bionomics Ltd ADR, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Bionomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Bionomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Bionomics.
Diversification Opportunities for Virpax Pharmaceuticals and Bionomics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Bionomics is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Bionomics Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionomics ADR and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Bionomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionomics ADR has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Bionomics go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Bionomics
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Bionomics. But the stock apears to be less risky and, when comparing its historical volatility, Virpax Pharmaceuticals is 1.65 times less risky than Bionomics. The stock trades about -0.02 of its potential returns per unit of risk. The Bionomics Ltd ADR is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 420.00 in Bionomics Ltd ADR on August 27, 2024 and sell it today you would lose (391.00) from holding Bionomics Ltd ADR or give up 93.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Bionomics Ltd ADR
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Bionomics ADR |
Virpax Pharmaceuticals and Bionomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Bionomics
The main advantage of trading using opposite Virpax Pharmaceuticals and Bionomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Bionomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will offset losses from the drop in Bionomics' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Bionomics vs. Accustem Sciences | Bionomics vs. Scisparc | Bionomics vs. Anebulo Pharmaceuticals | Bionomics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |